These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 11583067)

  • 1. Topical tacrolimus for the treatment of inflammatory skin diseases.
    Assmann T; Homey B; Ruzicka T
    Expert Opin Pharmacother; 2001 Jul; 2(7):1167-75. PubMed ID: 11583067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrolimus ointment: new preparation. Too many unknowns.
    Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
    Cheer SM; Plosker GL
    Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tacrolimus in the treatment of atopic dermatitis.
    Gianni LM; Sulli MM
    Ann Pharmacother; 2001; 35(7-8):943-6. PubMed ID: 11485148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus treatment of atopic eczema/dermatitis syndrome.
    Thestrup-Pedersen K
    Curr Opin Allergy Clin Immunol; 2003 Oct; 3(5):359-62. PubMed ID: 14501435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects.
    Rico MJ; Lawrence I
    Allergy Asthma Proc; 2002; 23(3):191-7. PubMed ID: 12125507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group.
    Reitamo S; Wollenberg A; Schöpf E; Perrot JL; Marks R; Ruzicka T; Christophers E; Kapp A; Lahfa M; Rubins A; Jablonska S; Rustin M
    Arch Dermatol; 2000 Aug; 136(8):999-1006. PubMed ID: 10926735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of tacrolimus for the treatment of skin disorders.
    Assmann T; Homey B; Ruzicka T
    Immunopharmacology; 2000 May; 47(2-3):203-13. PubMed ID: 10878290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of ascomycin analogs with potent topical but weak systemic activity for treatment of inflammatory skin diseases.
    Mollison KW; Fey TA; Gauvin DM; Sheets MP; Smith ML; Pong M; Krause R; Miller L; Or YS; Kawai M; Wagner R; Wiedeman PE; Clark RF; Gunawardana IW; Rhoades TA; Henry CL; Tu NP; BaMaung NY; Kopecka H; Liu L; Xie Q; Lane BC; Trevillyan JM; Marsh K; Luly JR
    Curr Pharm Des; 1998 Oct; 4(5):367-79. PubMed ID: 10197049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis.
    Reitamo S; Remitz A; Kyllönen H; Saarikko J
    Am J Clin Dermatol; 2002; 3(6):381-8. PubMed ID: 12113647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical pimecrolimus: a review of its clinical potential in the management of atopic dermatitis.
    Wellington K; Jarvis B
    Drugs; 2002; 62(5):817-40. PubMed ID: 11929333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
    Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
    Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tacrolimus.
    Frankel SJ; Kerdel FA
    Skin Therapy Lett; 2001; 6(4):1-2, 5. PubMed ID: 11176043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive macrolides and their use in dermatology].
    Bornhövd EC; Schuller E; Bieber T; Wollenberg A
    Hautarzt; 2000 Sep; 51(9):646-54. PubMed ID: 11057390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A; Allen BR; Reitamo S
    J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.